Cellectis Statistics
Total Valuation
Cellectis has a market cap or net worth of EUR 210.20 million. The enterprise value is 154.81 million.
Market Cap | 210.20M |
Enterprise Value | 154.81M |
Important Dates
The next estimated earnings date is Friday, September 6, 2024.
Earnings Date | Sep 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Cellectis has 100.09 million shares outstanding.
Shares Outstanding | 100.09M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 1.52% |
Owned by Institutions (%) | 15.36% |
Float | 71.46M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 8.10 |
PB Ratio | 1.52 |
P/FCF Ratio | 4.54 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.10 |
EV / Sales | 8.45 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 3.34 |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 60.36.
Current Ratio | 1.92 |
Quick Ratio | 1.10 |
Debt / Equity | 60.36 |
Debt / EBITDA | n/a |
Debt / FCF | 1.81 |
Interest Coverage | -13.16 |
Financial Efficiency
Return on equity (ROE) is -64.37% and return on invested capital (ROIC) is -26.00%.
Return on Equity (ROE) | -64.37% |
Return on Assets (ROA) | -17.30% |
Return on Capital (ROIC) | -26.00% |
Revenue Per Employee | 83,677 |
Profits Per Employee | -336,265 |
Employee Count | 219 |
Asset Turnover | 0.06 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.81% in the last 52 weeks. The beta is 3.22, so Cellectis's price volatility has been higher than the market average.
Beta (5Y) | 3.22 |
52-Week Price Change | +8.81% |
50-Day Moving Average | 1.86 |
200-Day Moving Average | 2.36 |
Relative Strength Index (RSI) | 64.22 |
Average Volume (20 Days) | 42,626 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cellectis had revenue of EUR 18.33 million and -73.64 million in losses. Loss per share was -1.04.
Revenue | 18.33M |
Gross Profit | 17.64M |
Operating Income | -82.00M |
Pretax Income | -73.96M |
Net Income | -73.64M |
EBITDA | -72.23M |
EBIT | -82.00M |
Loss Per Share | -1.04 |
Balance Sheet
The company has 139.10 million in cash and 83.72 million in debt, giving a net cash position of 55.38 million or 0.55 per share.
Cash & Cash Equivalents | 139.10M |
Total Debt | 83.72M |
Net Cash | 55.38M |
Net Cash Per Share | 0.55 |
Equity (Book Value) | 138.70M |
Book Value Per Share | 1.39 |
Working Capital | 136.42M |
Cash Flow
In the last 12 months, operating cash flow was 48.05 million and capital expenditures -1.72 million, giving a free cash flow of 46.33 million.
Operating Cash Flow | 48.05M |
Capital Expenditures | -1.72M |
Free Cash Flow | 46.33M |
FCF Per Share | 0.46 |
Margins
Gross Margin | 96.25% |
Operating Margin | -447.44% |
Pretax Margin | -403.60% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | 252.82% |
Dividends & Yields
Cellectis does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -49.61% |
FCF Yield | 22.04% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |